AAPL312.42+3.79 (+1.23%) ▲|ABBV256.39-4.68 (-1.79%) ▼|ABT95.72+0.32 (+0.34%) ▲|ACN136.93-0.42 (-0.31%) ▼|ADBE218.15-1.58 (-0.72%) ▼|AMAT595.55-7.49 (-1.24%) ▼|AMD553.13+35.31 (+6.82%) ▲|AMGN365.56-8.59 (-2.30%) ▼|AMT161.30-4.73 (-2.85%) ▼|AMZN244.91+2.24 (+0.92%) ▲|AVGO375.77+15.32 (+4.25%) ▲|AXP356.44+4.48 (+1.27%) ▲|BA232.73+6.24 (+2.76%) ▲|BAC59.83+1.10 (+1.86%) ▲|BKNG182.35-2.21 (-1.20%) ▼|BLK1,004.88+9.15 (+0.92%) ▲|BMY56.89-1.25 (-2.14%) ▼|BNY149.66+3.04 (+2.07%) ▲|BRK-B506.99-0.79 (-0.16%) ▼|C142.98+3.01 (+2.15%) ▲|CAT971.51+7.98 (+0.83%) ▲|CL93.09-2.05 (-2.15%) ▼|CMCSA23.56-0.24 (-0.99%) ▼|COF206.01+0.89 (+0.43%) ▲|COP103.87-0.86 (-0.82%) ▼|COST947.13-4.55 (-0.48%) ▼|CRM166.34+0.23 (+0.14%) ▲|CSCO114.07+1.38 (+1.22%) ▲|CVS102.39-2.33 (-2.23%) ▼|CVX168.18-1.02 (-0.60%) ▼|DE632.31+11.04 (+1.78%) ▲|DHR194.61-3.33 (-1.68%) ▼|DIS97.42-2.08 (-2.09%) ▼|DUK126.56-3.05 (-2.35%) ▼|EMR141.38+2.33 (+1.68%) ▲|FDX309.18-3.83 (-1.22%) ▼|GD376.19+2.65 (+0.71%) ▲|GE378.28+1.23 (+0.32%) ▲|GEV1,155.55+42.44 (+3.81%) ▲|GILD129.15-2.12 (-1.62%) ▼|GM77.85+1.85 (+2.43%) ▲|GOOG361.64+5.46 (+1.53%) ▲|GOOGL364.27+4.36 (+1.21%) ▲|GS1,045.02+24.02 (+2.35%) ▲|HD352.09-5.81 (-1.62%) ▼|HON228.18-1.69 (-0.73%) ▼|IBM297.98+8.46 (+2.92%) ▲|INTC122.73+2.38 (+1.98%) ▲|INTU270.61-4.74 (-1.72%) ▼|ISRG437.15+11.14 (+2.62%) ▲|JNJ259.24-3.81 (-1.45%) ▼|JPM337.04+4.07 (+1.22%) ▲|KO83.30-0.84 (-1.00%) ▼|LIN536.71-9.93 (-1.82%) ▼|LLY1,207.78-6.13 (-0.51%) ▼|LMT538.28-7.63 (-1.40%) ▼|LOW224.20-3.30 (-1.45%) ▼|LRCX351.23-0.18 (-0.05%) ▼|MA533.55-5.84 (-1.08%) ▼|MCD278.06-2.57 (-0.92%) ▼|MDLZ59.25-1.66 (-2.73%) ▼|MDT83.65+0.46 (+0.55%) ▲|META594.14+11.24 (+1.93%) ▲|MMM158.53-1.92 (-1.19%) ▼|MO72.13-0.59 (-0.80%) ▼|MRK126.77-2.79 (-2.15%) ▼|MS220.51+6.58 (+3.08%) ▲|MSFT384.73-5.76 (-1.48%) ▼|MU986.17+10.61 (+1.09%) ▲|NEE87.59-0.75 (-0.85%) ▼|NFLX76.15-1.51 (-1.94%) ▼|NKE43.08-1.01 (-2.29%) ▼|NOW108.57+2.25 (+2.12%) ▲|NVDA195.70+0.87 (+0.45%) ▲|ORCL143.07+2.80 (+2.00%) ▲|PEP143.13-1.09 (-0.76%) ▼|PFE23.83-0.50 (-2.04%) ▼|PG148.92-2.49 (-1.64%) ▼|PLTR131.43+2.13 (+1.64%) ▲|PM184.74+2.47 (+1.36%) ▲|QCOM185.57+9.32 (+5.29%) ▲|RTX200.91+1.66 (+0.83%) ▲|SBUX101.32-2.96 (-2.83%) ▼|SCHW100.79+3.79 (+3.91%) ▲|SO96.14-1.84 (-1.88%) ▼|SPG224.87-1.19 (-0.53%) ▼|T20.57-0.02 (-0.07%) ▼|TMO516.75-6.69 (-1.28%) ▼|TMUS181.37+3.85 (+2.17%) ▲|TSLA415.09+21.64 (+5.50%) ▲|TXN303.30+10.22 (+3.49%) ▲|UBER73.34-1.09 (-1.46%) ▼|UNH417.35-8.01 (-1.88%) ▼|UNP282.40+0.15 (+0.05%) ▲|UPS110.05-0.61 (-0.55%) ▼|USB63.01+1.28 (+2.07%) ▲|V357.53-4.61 (-1.27%) ▼|VZ41.98-0.59 (-1.37%) ▼|WFC87.53+2.02 (+2.36%) ▲|WMT110.44-1.40 (-1.25%) ▼|XOM136.98-0.11 (-0.08%) ▼|AAPL312.42+3.79 (+1.23%) ▲|ABBV256.39-4.68 (-1.79%) ▼|ABT95.72+0.32 (+0.34%) ▲|ACN136.93-0.42 (-0.31%) ▼|ADBE218.15-1.58 (-0.72%) ▼|AMAT595.55-7.49 (-1.24%) ▼|AMD553.13+35.31 (+6.82%) ▲|AMGN365.56-8.59 (-2.30%) ▼|AMT161.30-4.73 (-2.85%) ▼|AMZN244.91+2.24 (+0.92%) ▲|AVGO375.77+15.32 (+4.25%) ▲|AXP356.44+4.48 (+1.27%) ▲|BA232.73+6.24 (+2.76%) ▲|BAC59.83+1.10 (+1.86%) ▲|BKNG182.35-2.21 (-1.20%) ▼|BLK1,004.88+9.15 (+0.92%) ▲|BMY56.89-1.25 (-2.14%) ▼|BNY149.66+3.04 (+2.07%) ▲|BRK-B506.99-0.79 (-0.16%) ▼|C142.98+3.01 (+2.15%) ▲|CAT971.51+7.98 (+0.83%) ▲|CL93.09-2.05 (-2.15%) ▼|CMCSA23.56-0.24 (-0.99%) ▼|COF206.01+0.89 (+0.43%) ▲|COP103.87-0.86 (-0.82%) ▼|COST947.13-4.55 (-0.48%) ▼|CRM166.34+0.23 (+0.14%) ▲|CSCO114.07+1.38 (+1.22%) ▲|CVS102.39-2.33 (-2.23%) ▼|CVX168.18-1.02 (-0.60%) ▼|DE632.31+11.04 (+1.78%) ▲|DHR194.61-3.33 (-1.68%) ▼|DIS97.42-2.08 (-2.09%) ▼|DUK126.56-3.05 (-2.35%) ▼|EMR141.38+2.33 (+1.68%) ▲|FDX309.18-3.83 (-1.22%) ▼|GD376.19+2.65 (+0.71%) ▲|GE378.28+1.23 (+0.32%) ▲|GEV1,155.55+42.44 (+3.81%) ▲|GILD129.15-2.12 (-1.62%) ▼|GM77.85+1.85 (+2.43%) ▲|GOOG361.64+5.46 (+1.53%) ▲|GOOGL364.27+4.36 (+1.21%) ▲|GS1,045.02+24.02 (+2.35%) ▲|HD352.09-5.81 (-1.62%) ▼|HON228.18-1.69 (-0.73%) ▼|IBM297.98+8.46 (+2.92%) ▲|INTC122.73+2.38 (+1.98%) ▲|INTU270.61-4.74 (-1.72%) ▼|ISRG437.15+11.14 (+2.62%) ▲|JNJ259.24-3.81 (-1.45%) ▼|JPM337.04+4.07 (+1.22%) ▲|KO83.30-0.84 (-1.00%) ▼|LIN536.71-9.93 (-1.82%) ▼|LLY1,207.78-6.13 (-0.51%) ▼|LMT538.28-7.63 (-1.40%) ▼|LOW224.20-3.30 (-1.45%) ▼|LRCX351.23-0.18 (-0.05%) ▼|MA533.55-5.84 (-1.08%) ▼|MCD278.06-2.57 (-0.92%) ▼|MDLZ59.25-1.66 (-2.73%) ▼|MDT83.65+0.46 (+0.55%) ▲|META594.14+11.24 (+1.93%) ▲|MMM158.53-1.92 (-1.19%) ▼|MO72.13-0.59 (-0.80%) ▼|MRK126.77-2.79 (-2.15%) ▼|MS220.51+6.58 (+3.08%) ▲|MSFT384.73-5.76 (-1.48%) ▼|MU986.17+10.61 (+1.09%) ▲|NEE87.59-0.75 (-0.85%) ▼|NFLX76.15-1.51 (-1.94%) ▼|NKE43.08-1.01 (-2.29%) ▼|NOW108.57+2.25 (+2.12%) ▲|NVDA195.70+0.87 (+0.45%) ▲|ORCL143.07+2.80 (+2.00%) ▲|PEP143.13-1.09 (-0.76%) ▼|PFE23.83-0.50 (-2.04%) ▼|PG148.92-2.49 (-1.64%) ▼|PLTR131.43+2.13 (+1.64%) ▲|PM184.74+2.47 (+1.36%) ▲|QCOM185.57+9.32 (+5.29%) ▲|RTX200.91+1.66 (+0.83%) ▲|SBUX101.32-2.96 (-2.83%) ▼|SCHW100.79+3.79 (+3.91%) ▲|SO96.14-1.84 (-1.88%) ▼|SPG224.87-1.19 (-0.53%) ▼|T20.57-0.02 (-0.07%) ▼|TMO516.75-6.69 (-1.28%) ▼|TMUS181.37+3.85 (+2.17%) ▲|TSLA415.09+21.64 (+5.50%) ▲|TXN303.30+10.22 (+3.49%) ▲|UBER73.34-1.09 (-1.46%) ▼|UNH417.35-8.01 (-1.88%) ▼|UNP282.40+0.15 (+0.05%) ▲|UPS110.05-0.61 (-0.55%) ▼|USB63.01+1.28 (+2.07%) ▲|V357.53-4.61 (-1.27%) ▼|VZ41.98-0.59 (-1.37%) ▼|WFC87.53+2.02 (+2.36%) ▲|WMT110.44-1.40 (-1.25%) ▼|XOM136.98-0.11 (-0.08%) ▼|
21 C
New York
Monday, July 6, 2026

Tag: release

newssourceFORcompanyinformationcontent1releasesmarket

Oceana Calls on Governments to Put Coastal Communities First at Our Ocean Conference in Kenya

Actor Kate Walsh to join Oceana in Mombasa at Our Ocean Conference to meet with local fishers and elevate coastal voices in global ocean decision making

JJP Biologics Announces Positive Interim Phase 1b Data for Nebaprubart (JJP-1212), an Anti-CD89 Antagonist, in Linear IgA Disease (LAD)

Warsaw, Poland – June 03, 2026 – JJP Biologics, ("JJPBio" or the "Company") a clinical-stage, immune-focused biotech that engineers precision antibodies to correct derailed immune pathways that drive autoimmune diseases and cancer, today announces positive interim data from its ongoing Phase 1b trial evaluating nebaprubart, also known as JJP-1212, its investigational potential first-in-class anti-CD89 antagonist, in patients diagnosed with Linear IgA Disease (LAD), a rare autoantibody-mediated skin disease.

Sigenergy (HKEX: 6656.HK) Launches SigenAgent, a Goal-Based AI Energy Agent for Solar, Storage and EV Charging

Designed to shift energy management from manual device control to goal-based optimization, SigenAgent lets users define outcomes while AI recommends and coordinates execution 
Designed to shift energy management from manual device control to goal-based optimization, SigenAgent lets users define outcomes while AI recommends and coordinates execution

Johnson & Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) disease activity in a Phase 2 study

Nipocalimab – the first and only neonatal Fc receptor (FcRn) blocker to be studied in systemic lupus erythematosus – is designed to target and...

Antengene to Present First Preclinical Data on ATG-207 (αCD3-TGF-β Bifunctional Fusion Protein) at EULAR 2026

SHANGHAI and HONG KONG, June 3, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated...

SEALSQ Participates as a Lead Investor in Quobly’s €130 Million Series A Financing Via SEALQuantum.com Fund to Advance the European Sovereign Quantum Infrastructure

Geneva, Switzerland, June 03, 2026 (GLOBE NEWSWIRE) --

SEALSQ Corp (NASDAQ: LAES), ("SEALSQ" or "Company"), a leader in post-quantum semiconductor technologies and hardware-anchored security solutions, today announced its participation as a lead investor in Quobly’s €130 million Series A financing. The round is led by ST Microelectronics, SEALSQ, Isalt, and the French Public Investment Bank (BPI France).

TETRA Technologies, Inc. Announces Pricing of Public Offering of Common Stock

SPRING, Texas, June 2, 2026 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE: TTI) today announced the pricing of an underwritten public...

Generación Mediterránea S.A. and Central Térmica Roca S.A. Announce Participation Results of their Previously Announced Exchange Offer and Consent Solicitation

HIGHLIGHTSUS$346,457,132 of Existing Notes, or 97.88% of all Existing Notes, have been tenderedThe Companies have met the Minimum Participation Condition and the Clean-Up Call...

Snail Games 慶祝《ARK》在推出 11 年後持續擴充

加州卡爾弗城, June 03, 2026 (GLOBE NEWSWIRE) -- 全球領先的獨立互動數碼娛樂開發商與發行商 Snail, Inc. (Nasdaq: SNAL) (下稱「Snail Games」或「公司」)，今天慶祝《ARK》系列推出 11 週年，並強調遊戲持續的商業增長動力、不斷擴充的內容路線圖，以及《ARK》系列的長期發展策略。

ASCO 2026 | Updated Data from an Oral Presentation of InnoCare’s Novel BCL2 Inhibitor Mesutoclax in MDS and AML Released

InnoCare's novel BCL2i mesutoclax in MDS and AML was released at 2026 ASCO as an oral presentation, demonstrating outstanding efficacy and safety.

חדשות למשקיעים ב- IRON: אם סבלתם הפסדים ב- Disc Medicine, Inc (נאסד”ק: IRON), אתם מוזמנים ליצור קשר עם משרד רוזן עורכי הדין בנוגע לזכויותיכם

ניו יורק, June 03, 2026 (GLOBE NEWSWIRE) --

מדוע: משרד רוזן עורכי דין (Rosen Law Firm), משרד עורכי דין בינלאומי העוסק בזכויות משקיעים, ממשיך לחקור תביעות ניירות ערך פוטנציאליות מטעם בעלי המניות של Disc Medicine, Inc (נאסד"ק: IRON) הנובעות מטענות לפיהן יתכן ש-  Disc Medicine פרסמה מידע עסקי מטעה באופן מהותי לציבור המשקיעים.

Opus One Private Preview Event and Official Launch Celebration

Canadian and global investors gain early access to Opus One, a luxury residential development in IndiaMISSISSAUGA, ON, June 2, 2026 /CNW/ - Captain Advisory...

Sportradar Securities Fraud Class Action Result of Compliance Misrepresentations and 22% Stock Decline – Investors may Contact Lewis Kahn, Esq, at Kahn Swick &...

Sportradar (SRAD) Investors Have Opportunity to Lead Sportradar Group AG Securities Fraud Lawsuit

Crypto Market News: AlphaPepe Presale Gathers Pace While Bitcoin Price Prediction Targets $50,000 Support

MONACO, June 02, 2026 (GLOBE NEWSWIRE) -- Crypto market news is turning toward AlphaPepe as the project’s presale continues to gather pace ahead of its planned Q2 2026 exchange debut. The presale has now crossed $1.45 million in total capital raised, Stage 17 is live at $0.01822, and holder growth has climbed past 9,200 while AlphaSwap demo traction and audit completion continue to support the project’s pre-listing profile.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsRelease

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers